REPARE THERAPEUTICS INC filings

SEC filings by REPARE THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14Redmile Group, LLCRepare Therapeutics Inc.2,148,7485.1%EDGAR
SC 13G/A2024-02-14Deep Track Capital, LPRepare Therapeutics Inc.2,992,7317.1%EDGAR
SC 13G2024-02-14Blue Owl Capital Holdings LPRepare Therapeutics Inc.3,122,4997.4%EDGAR
SC 13G/A2024-01-29ARK Investment Management LLCRepare Therapeutics Inc.2,821,5606.7%EDGAR
SC 13D/A2023-11-17BIOTECHNOLOGY VALUE FUND L PRepare Therapeutics Inc.5,309,43212.6%EDGAR
SC 13D2023-11-03BIOTECHNOLOGY VALUE FUND L PRepare Therapeutics Inc.4,662,40211.1%EDGAR
SC 13G/A2023-02-14PRICE T ROWE ASSOCIATES INC /MD/Repare Therapeutics Inc.26,8940.1%EDGAR
SC 13G/A2023-02-14BIOTECHNOLOGY VALUE FUND L PRepare Therapeutics Inc.4,443,42310.6%EDGAR
SC 13G/A2023-02-14Redmile Group, LLCRepare Therapeutics Inc.2,684,3966.4%EDGAR
SC 13G/A2023-02-14Deep Track Capital, LPRepare Therapeutics Inc.2,727,6066.5%EDGAR
SC 13G/A2023-02-13CHI Advisors LLCRepare Therapeutics Inc.2,800,1266.7%EDGAR
SC 13G/A2023-02-10ARK Investment Management LLCRepare Therapeutics Inc.2,428,0555.8%EDGAR
SC 13G/A2023-02-09FMR LLCRepare Therapeutics Inc.876,1782.1%EDGAR
SC 13D/A2023-01-06Versant Venture Capital V, L.P.Repare Therapeutics Inc.563,4031.3%EDGAR
SC 13D/A2022-06-13Versant Venture Capital V, L.P.Repare Therapeutics Inc.850,5602.0%EDGAR
SC 13G/A2022-06-06BIOTECHNOLOGY VALUE FUND L PRepare Therapeutics Inc.4,368,75710.4%EDGAR
SC 13G/A2022-02-14BIOTECHNOLOGY VALUE FUND L PRepare Therapeutics Inc.2,548,7646.1%EDGAR
SC 13G/A2022-02-14Redmile Group, LLCRepare Therapeutics Inc.2,789,4966.7%EDGAR
SC 13G/A2022-02-14Deep Track Capital, LPRepare Therapeutics Inc.2,100,0005.0%EDGAR
SC 13G2022-02-14PRICE T ROWE ASSOCIATES INC /MD/Repare Therapeutics Inc.2,166,8225.1%EDGAR